Publications by authors named "Thomas Heitzer"

Claim this Profile
P
Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: two-year results of the ENERGY Registry.
Raimund Erbel, Holger Eggebrecht, Ariel Roguin, Erwin Schroeder, Sebastian Philipp, Thomas Heitzer

Cardiovasc Revasc Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
Nils Kucher, Peter Boekstegers, Oliver J Müller, Christian Kupatt, Jan Beyer-Westendorf, Thomas Heitzer

Circulation· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the long-term outcome after pulmonary vein isolation for paroxysmal atrial fibrillation.
Hanno U Klemm, Thomas Heitzer, Ute Ruprecht, Thomas Meinertz, Rodolfo Ventura

Cardiology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of an expert system for the discrimination of local pulmonary vein and atrial far field signals.
Hanno Ulrich Klemm, Thomas Heitzer, Ute Ruprecht, Christin Johnsen, Thomas Meinertz

J Interv Card Electrophysiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function.
Tanja K Rudolph, Volker Rudolph, Anna Witte, Anna Klinke, Katalin Szoecs, Thomas Heitzer

Int J Cardiol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of quantitative coronary angiography and first-pass perfusion magnetic resonance imaging for the detection of an impaired coronary perfusion in nonsevere coronary stenosis.
Achim A Barmeyer, Alexander Stork, Kai Muellerleile, Anne K Schofer, Claudia Tiburtius, Thomas Heitzer

J Magn Reson Imaging· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired capacity for acute endogenous fibrinolysis in smokers is restored by ascorbic acid.
Jan Kaehler, Katharina Koeke, Manuela Karstens, Reinhard Schneppenheim, Thomas Meinertz, Thomas Heitzer

Free Radic Biol Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease.
Ascan Warnholtz, Mir Abolfazl Ostad, Thomas Heitzer, Felix Thuneke, Meike Fröhlich

Atherosclerosis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function.
Volker Rudolph, Tanja K Rudolph, J Christopher Hennings, Stefan Blankenberg, Renate Schnabel, Thomas Heitzer

Free Radic Biol Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-enhanced cardiac MR imaging in the detection of reduced coronary flow velocity reserve.
Achim A Barmeyer, Alexander Stork, Kai Muellerleile, Claudia Tiburtius, Anne K Schofer, Thomas A Heitzer

Radiology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study.
Rainer Hoffmann, Tilmann Pohl, Ralf Köster, Ruediger Blindt, Peter Boeckstegers, Thomas Heitzer

Heart· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease.
Volker Rudolph, Daniel Steven, Ursula M Gehling, Britta Goldmann, Tanja K Rudolph, Thomas Heitzer

Free Radic Biol Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
Stephan Baldus, Kai Müllerleile, Phil Chumley, Daniel Steven, Volker Rudolph, Thomas Heitzer

Free Radic Biol Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
Thomas Heitzer, Volker Rudolph, Edzard Schwedhelm, Manuela Karstens, Karsten Sydow

Arterioscler Thromb Vasc Biol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
Stephan Baldus, Volker Rudolph, Mika Roiss, Wulf D Ito, Tanja K Rudolph, Thomas Heitzer

Circulation· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.
Stephan Baldus, Ralf Köster, Phillip Chumley, Thomas Heitzer, Volker Rudolph

Free Radic Biol Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure.
Thomas Heitzer, Stephan Baldus, Yskert von Kodolitsch, Volker Rudolph, Thomas Meinertz

Arterioscler Thromb Vasc Biol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease.
Ascan Warnholtz, Mir Abolfazl Ostad, Thomas Heitzer, Britta U Goldmann, Goetz Nowak

Am J Cardiol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.
Denise Lau, Hanke Mollnau, Jason P Eiserich, Bruce A Freeman, Andreas Daiber, Thomas Heitzer

Proc Natl Acad Sci U S A· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.
Stephan Baldus, Thomas Heitzer, Jason P Eiserich, Denise Lau, Hanke Mollnau

Free Radic Biol Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.
Thomas Heitzer, Isabel Ollmann, Katharina Köke, Thomas Meinertz, Thomas Munzel

Circulation· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits.
Ascan Warnholtz, Hanke Mollnau, Thomas Heitzer, Anatol Kontush, Tobias Möller-Bertram

J Am Coll Cardiol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis